United States · Exchanges & live quotes · Nasdaq
Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook
(RTTNews) - Novo Nordisk A/S (NVO, NOVOB.CO, NOV.DE) reported third quarter net profit of 16.74 billion Danish kroner, a decline of 16% year-over-year. Earnings per share/ ADR was…
Read the full article on Nasdaq Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)


